Plandai Biotechnology Inc
(OTCPK:PLPL)
$0.0002
0[0.00%]
Last update: 3:59PM (Delayed 15-Minutes)
Get Real Time Here
Open-Close-
Vol / Avg.0 / 47.297MMkt Cap52.638K
Day Range- - -52 Wk Range0.000 - 0.002

Plandai Biotechnology Stock (OTC:PLPL), Key Statistics

Plandai Biotechnology Stock (OTC: PLPL) analysis, key statistics.

Valuation Measures
Enterprise Value
236.9K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
20.8M
Total Assets
6.8M
Total Liabilities
20.8M
Profitability
Net income Growth
- -
Gross Margin
-8.32%
Net Margin
-321.08%
EBIT Margin
-154.62%
EBITDA Margin
-102.36%
Operating Margin
-291.89%

Plandai Biotechnology Stock (OTC:PLPL), Key Statistics

Plandai Biotechnology Stock (OTC: PLPL) analysis, key statistics.

Valuation Measures
Enterprise Value
236.9K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
20.8M
Total Assets
6.8M
Total Liabilities
20.8M
Profitability
Net income Growth
- -
Gross Margin
-8.32%
Net Margin
-321.08%
EBIT Margin
-154.62%
EBITDA Margin
-102.36%
Operating Margin
-291.89%

Plandai Biotechnology Stock (OTC:PLPL), Key Statistics

Plandai Biotechnology Stock (OTC: PLPL) analysis, key statistics.

Valuation Measures
Enterprise Value
236.9K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
20.8M
Total Assets
6.8M
Total Liabilities
20.8M
Profitability
Net income Growth
- -
Gross Margin
-8.32%
Net Margin
-321.08%
EBIT Margin
-154.62%
EBITDA Margin
-102.36%
Operating Margin
-291.89%

Plandai Biotechnology Stock (OTC:PLPL), Key Statistics

Plandai Biotechnology Stock (OTC: PLPL) analysis, key statistics.

Valuation Measures
Enterprise Value
236.9K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
20.8M
Total Assets
6.8M
Total Liabilities
20.8M
Profitability
Net income Growth
- -
Gross Margin
-8.32%
Net Margin
-321.08%
EBIT Margin
-154.62%
EBITDA Margin
-102.36%
Operating Margin
-291.89%

Plandai Biotechnology Stock (OTC:PLPL), Key Statistics

Plandai Biotechnology Stock (OTC: PLPL) analysis, key statistics.

Valuation Measures
Enterprise Value
236.9K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
20.8M
Total Assets
6.8M
Total Liabilities
20.8M
Profitability
Net income Growth
- -
Gross Margin
-8.32%
Net Margin
-321.08%
EBIT Margin
-154.62%
EBITDA Margin
-102.36%
Operating Margin
-291.89%

Plandai Biotechnology Stock (OTC:PLPL), Key Statistics

Plandai Biotechnology Stock (OTC: PLPL) analysis, key statistics.

Valuation Measures
Enterprise Value
236.9K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
20.8M
Total Assets
6.8M
Total Liabilities
20.8M
Profitability
Net income Growth
- -
Gross Margin
-8.32%
Net Margin
-321.08%
EBIT Margin
-154.62%
EBITDA Margin
-102.36%
Operating Margin
-291.89%

Plandai Biotechnology Stock (OTC:PLPL), Key Statistics

Plandai Biotechnology Stock (OTC: PLPL) analysis, key statistics.

Valuation Measures
Enterprise Value
236.9K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
20.8M
Total Assets
6.8M
Total Liabilities
20.8M
Profitability
Net income Growth
- -
Gross Margin
-8.32%
Net Margin
-321.08%
EBIT Margin
-154.62%
EBITDA Margin
-102.36%
Operating Margin
-291.89%

Plandai Biotechnology Stock (OTC:PLPL), Key Statistics

Plandai Biotechnology Stock (OTC: PLPL) analysis, key statistics.

Valuation Measures
Enterprise Value
236.9K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
20.8M
Total Assets
6.8M
Total Liabilities
20.8M
Profitability
Net income Growth
- -
Gross Margin
-8.32%
Net Margin
-321.08%
EBIT Margin
-154.62%
EBITDA Margin
-102.36%
Operating Margin
-291.89%

Plandai Biotechnology Stock (OTC:PLPL), Key Statistics

Plandai Biotechnology Stock (OTC: PLPL) analysis, key statistics.

Valuation Measures
Enterprise Value
236.9K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
20.8M
Total Assets
6.8M
Total Liabilities
20.8M
Profitability
Net income Growth
- -
Gross Margin
-8.32%
Net Margin
-321.08%
EBIT Margin
-154.62%
EBITDA Margin
-102.36%
Operating Margin
-291.89%